









Markets
/
Stocks
/
nasdaq-masi
/

Masimo Corp

MASI

145.720USD

-1.720-1.17%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

7.91BMarket Cap

LossP/E TTM



Masimo Corp

145.720

-1.720-1.17%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

28 / 207

Overall Ranking

137 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 9 analysts

Buy

Current Rating

187.116

Target Price

+26.91%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD 304.90M.%!(EXTRA int=2)

Undervalued

The company’s latest PE is -17.17, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 59.97M shares, decreasing 11.15% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 4.63M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.26.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 7.46, which is higher than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 372.00M, representing a year-over-year increase of 9.54%, while its net profit experienced a year-over-year increase of 1003.17%.

Score

Industry at a Glance

Previous score

7.46

Change



Financials

7.79

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.85

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.26

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.19

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.20

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is -16.60, which is -577.73% below the recent high of 79.29 and 374.83% above the recent low of 45.62.

Score

Industry at a Glance

Previous score

1.20

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 28/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

The company’s current earnings forecast score is 8.22, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Masimo Corp is 184.47, with a high of 210.00 and a low of 170.00.

Score

Industry at a Glance

Previous score

8.22

Change

Support & Resistance

No Data

Analyst Rating

Based on 9 analysts

Buy

Current Rating

187.116

Target Price

+26.91%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Masimo Corp

MASI

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 6.95, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 159.26 and the support level at 130.77, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.21

Change

0.12

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

1.953

Neutral

RSI(14)

47.210

Neutral

STOCH(KDJ)(9,3,3)

74.793

Neutral

ATR(14)

3.957

High Vlolatility

CCI(14)

59.204

Neutral

Williams %R

28.928

Buy

TRIX(12,20)

-0.210

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

146.662

Sell

MA10

144.681

Buy

MA20

144.879

Buy

MA50

152.379

Sell

MA100

157.173

Sell

MA200

163.667

Sell

Institutional Confidence

Currency: USD Updated：2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 110.39%, representing a quarter-over-quarter increase of 0.39%. The largest institutional shareholder is The Vanguard, holding a total of 4.63M shares, representing 8.52% of shares outstanding, with 0.34% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

6.93M

+0.38%

The Vanguard Group, Inc.

Star Investors

4.57M

-0.07%

Politan Capital Management, L.P.

4.72M

+0.04%

BlackRock Institutional Trust Company, N.A.

4.13M

-25.40%

BlackRock Investment Management (UK) Ltd.

2.73M

+74.98%

Kiani (Joe E)

4.11M

-1.81%

T. Rowe Price Investment Management, Inc.

1.67M

+0.65%

MFS Investment Management

1.96M

+13.36%

Capital Research Global Investors

2.06M

-16.25%

BlackRock Financial Management, Inc.

1.74M

-10.65%

Risk Assessment

Currency: USD Updated：2025-09-12

The company's beta value is 1.23. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.